Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qilu Antibiotics Pharmaceutical is a major subsidiary of the Qilu Pharmaceutical Group, specializing in the development and large-scale production of antibiotic active pharmaceutical ingredients (APIs) and finished dosage forms. The company is recognized as one of the world's leading manufacturers of cephalosporins and penicillins, operating extensive GMP-certified facilities in Jinan and Linyi, China. Its products are exported to over 70 countries and regions, meeting international quality standards such as those set by the FDA, EDQM, and PMDA. Qilu Antibiotics plays a critical role in the global supply chain for anti-infective medications, providing both bulk substances and sterile powders for injection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qilu Antibiotics Pharmaceutical.